1561771-60-5

Basic information

• Product Name: (3-bromo-4-fluoro-1H-indazol-1-yl)(2-chloro-6-(trifluoromethyl)phenyl)methanone
• Synonyms: (3-bromo-4-fluoro-1H-indazol-1-yl)(2-chloro-6-(trifluoromethyl)phenyl)methanone
• CAS NO: 1561771-60-5
• Molecular Weight: 421.576
• Mol File: 1561771-60-5.mol
• Article Data: 5

Chemical Properties

• CAS DataBase Reference: (3-bromo-4-fluoro-1H-indazol-1-yl)(2-chloro-6-(trifluoromethyl)phenyl)methanone(CAS DataBase Reference)
• NIST Chemistry Reference: (3-bromo-4-fluoro-1H-indazol-1-yl)(2-chloro-6-(trifluoromethyl)phenyl)methanone(1561771-60-5)
• EPA Substance Registry System: (3-bromo-4-fluoro-1H-indazol-1-yl)(2-chloro-6-(trifluoromethyl)phenyl)methanone(1561771-60-5)

Safety Data

• Hazardous Substances Data: 1561771-60-5(Hazardous Substances Data)

Upstream product

• 916420-44-5 2-chloro-6-(trifluoromethyl)benzoyl chloride 
• 633328-33-3 3-bromo-1H-pyrazolo[4,3-b]pyridine 
• 341-23-1 4-fluoro-1H-indazole 
• 885521-60-8 3-bromo-4-fluoro-1H-indazole 

Downstream Products

• 1561769-37-6 1-(1-(2-chloro-6-(trifluoromethyl)benzoyl)-4-fluoro-1H-indazol-3-yl)pyrrolidine-3-carboxylic acid 

Relevant articles and documents

3-CYCLOHEXENYL AND CYCLOHEXYL SUBSTITUTED INDOLE AND INDAZOLE COMPOUNDS AS RORgammaT INHIBITORS AND USES THEREOF

The present invention relates to compounds according to Formula I and pharmaceutically acceptable salts or solvates thereof. Such compounds can be used in the treatment of RORgammaT-mediated diseases or conditions.

3-CYCLOHEXENYL SUBSTITUTED INDOLE AND INDAZOLE COMPOUNDS AS RORGAMMAT INHIBITORS AND USES THEREOF

Disclosed are compounds of Formula (I) or a pharmaceutically acceptable salt or solvate thereof. Such compounds can be used in the treatment of RORgammaT-mediated diseases or conditions.

3-AMINOCYCLOALKYL COMPOUNDS AS RORgammaT INHIBITORS AND USES THEREOF

The present invention relates to compounds according to Formula I and pharmaceutically acceptable salts or solvates thereof. Such compounds can be used in the treatment of RORgammaT-mediated diseases or conditions.